CAP TODAY

LDT thoughts offer nuance, and advice Two roads diverged in a regulated wood—and here comes Joe Lennerz, MD, PhD, happy not to be traveling both. https://lnkd.in/g5FbQS2H

Our August issue is now available online! Check it out here: https://lnkd.in/gm3NE3p9

Labs juggle string of LDT unknowns Like a long-awaited second act, the FDA’s final rule regulating laboratory-developed tests as medical devices took the stage this spring. As with any FDA performance, this one opened to mixed reviews. https://lnkd.in/gYivy_KX

How rapid autopsies bridge clinical care and research Meagan Chambers, MD, MS, MSc, feels like she has signed on for a life of being on call for 2 AM autopsies, and she says nothing could please her more. https://lnkd.in/g-QKtEbX

Idiopathic multicentric Castleman disease HOW CLINICAL AND HISTOPATHOLOGIC WORKUPS COME TOGETHER FOR A DEFINITIVE DIAGNOSIS Jadee Neff https://lnkd.in/gmzh_UUs

ADLM is fast approaching. We would love to sit down with you at the show to hear what is new or upcoming for your company! If you or your team is attending and interested in scheduling a meeting please message us here or contact your advertising director. Alex Pacheco: Midwest and East territory, alex@captoday.org Lori Prochaska: West and East territory, lori@captoday.org See you in Chicago!!

Did you know our Q&A column is one of our readers monthly favorites? Find it here: https://lnkd.in/gAVHcy7m

LGBT+ health: changes, challenges in cytopathology Screening in transgender men with cervices and in transgender women with neovaginas was the focus of a CAP23 session that highlighted screening recommendations and morphologic challenges such as detecting high-grade dysplasia in a background of atrophy (trans men) and dysplasia risks (trans women)—and EHR-related improvements for both Thank you to Margaret Compton, MD and Kim Adams Ely, MD. Full Article: https://lnkd.in/gkEbuEQ3

First looks and fast takes on LDT final rule The Food and Drug Administration’s final rule on laboratory-developed tests was released April 29 and published May 6. Shortly after, The Compass Group Laboratory Leaders leaders met online with CAP TODAY publisher Bob McGonnagle, who asked for their early reactions to what they heard and read. https://lnkd.in/gZCwUdQt

Check out CAP TODAY’s Publisher’s Picks which includes my selections of the most impactful articles from the second quarter of this year. I’ve chosen each for the interest to diagnostics and laboratory medicine. Though all of our articles are of great interest to our loyal readers, these stand out to me as exceptional. — Bob McGonnagle First looks and fast takes on LDT final rule: https://lnkd.in/gXwdBv2k Digging into the interpretation of TSH results:https://lnkd.in/enp3m7Nk Next-gen sequencing—the anxiety, optimism, and goal: https://lnkd.in/gEi5M59a How Duke’s molecular diagnostics lab retains and trains: https://lnkd.in/g4qGSrYF